Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of ABT-652 in Combination With a Nonsteroidal Anti-Inflammatory Drug (NSAID) in Adults With Osteoarthritis Pain of the Knee

ClinicalTrials.gov ID: NCT01444365

Public ClinicalTrials.gov record NCT01444365. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 7:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized Withdrawal Study of the Analgesic Efficacy and Safety of ABT-652 as an Add On Therapy in Subjects With Osteoarthritis of the Knee Experiencing Partial Benefit of a Nonsteroidal Anti-Inflammatory Drug

Study identification

NCT ID
NCT01444365
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AbbVie (prior sponsor, Abbott)
Industry
Enrollment
202 participants

Conditions and interventions

Interventions

  • ABT-652 NSAID Drug
  • Placebo NSAID Drug

Drug

Eligibility (public fields only)

Age range
40 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2011
Primary completion
Mar 31, 2012
Completion
Mar 31, 2012
Last update posted
May 14, 2013

2011 – 2012

United States locations

U.S. sites
31
U.S. states
16
U.S. cities
30
Facility City State ZIP Site status
Site Reference ID/Investigator# 61226 Phoenix Arizona 85023
Site Reference ID/Investigator# 61221 Phoenix Arizona 85032
Site Reference ID/Investigator# 61241 Tucson Arizona 85704
Site Reference ID/Investigator# 61257 Anaheim California 92801
Site Reference ID/Investigator# 61246 Fresno California 93726
Site Reference ID/Investigator# 61242 La Mesa California 91942
Site Reference ID/Investigator# 61204 Long Beach California 90806
Site Reference ID/Investigator# 61258 North Hollywood California 91606
Site Reference ID/Investigator# 61265 Milford Connecticut 06460
Site Reference ID/Investigator# 61234 DeLand Florida 32720
Site Reference ID/Investigator# 61213 Ocala Florida 34471
Site Reference ID/Investigator# 61211 Oldsmar Florida 34677
Site Reference ID/Investigator# 61217 Orlando Florida 32806
Site Reference ID/Investigator# 61231 Plantation Florida 33317
Site Reference ID/Investigator# 61245 Tampa Florida 33603
Site Reference ID/Investigator# 61263 Marietta Georgia 30060
Site Reference ID/Investigator# 61210 Brockton Massachusetts 02301
Site Reference ID/Investigator# 61260 Watertown Massachusetts 02472-3930
Site Reference ID/Investigator# 61244 Florissant Missouri 63031
Site Reference ID/Investigator# 61266 St Louis Missouri 63141
Site Reference ID/Investigator# 61206 Omaha Nebraska 68134
Site Reference ID/Investigator# 61223 Salisbury North Carolina 28144
Site Reference ID/Investigator# 61273 Cincinnati Ohio 45245
Site Reference ID/Investigator# 61228 Oklahoma City Oklahoma 73109
Site Reference ID/Investigator# 61264 Portland Oregon 97239
Site Reference ID/Investigator# 61238 Duncansville Pennsylvania 16635
Site Reference ID/Investigator# 61205 Beaumont Texas 77701
Site Reference ID/Investigator# 61218 Bryan Texas 77802
Site Reference ID/Investigator# 61235 San Antonio Texas 78209
Site Reference ID/Investigator# 61232 Draper Utah 84020
Site Reference ID/Investigator# 61269 Franklin Wisconsin 53132

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01444365, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 14, 2013 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01444365 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →